Cheap cholera vaccine succeeds in huge Phase III trial
This article was originally published in Scrip
Executive Summary
An affordable vaccine reduced the risk of cholera infection by over two-thirds, shows a large-scale Phase III clinical trial that was published today in the Lancet.